253 related articles for article (PubMed ID: 9797624)
1. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
Carnielli VP; Da Riol R; Montini G
Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human erythropoietin on transfusion needs in preterm infants.
Yeo CL; Choo S; Ho LY
J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human erythropoietin in infants with very low birth weights.
Samanci N; Ovali F; Dagoglu
J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229
[TBL] [Abstract][Full Text] [Related]
7. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.
Ohls RK; Harcum J; Schibler KR; Christensen RD
J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
[TBL] [Abstract][Full Text] [Related]
11. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
[TBL] [Abstract][Full Text] [Related]
12. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
15. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.
Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F
J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101
[TBL] [Abstract][Full Text] [Related]
16. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
Meyer MP; Haworth C; Meyer JH; Commerford A
J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants.
Akisu M; Tuzun S; Arslanoglu S; Yalaz M; Kultursay N
Acta Med Okayama; 2001 Dec; 55(6):357-62. PubMed ID: 11779098
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism.
Bechensteen AG; Halvorsen S; Hågå P; Cotes PM; Liestøl K
Acta Paediatr; 1996 Apr; 85(4):490-5. PubMed ID: 8740312
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.
Al-Kharfy T; Smyth JA; Wadsworth L; Krystal G; Fitzgerald C; Davis J; Milner R
J Pediatr; 1996 Jul; 129(1):89-96. PubMed ID: 8757567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
